HOME >> BIOLOGY >> NEWS
New model of staph drug resistance implicates unlikely protein

Findings may lead to new drugs that overcome resistance

Researchers at The Rockefeller University have established a new model to explain how the infectious "staph" bacterium evades several widely used antibiotics. They show that a protein previously thought to play no role in drug resistance in Staphylococcus aureus is, in fact, essential.

The new study, which is co-authored by Mariana Pinho, Hermnia de Lencastre, Ph.D, and Alexander Tomasz, Ph.D., and appears in the August 21 online edition of the Proceedings of the National Academy of Sciences, emphasizes the importance of looking for new antibiotics that target this protein.

"Mariana's work shows that the old model of drug resistance in staphylococci is no longer tenable," says Tomasz, principal investigator of the research and professor at Rockefeller.

Since the introduction of antibiotics in the 1940s, Staphylococcus aureus, the number one cause of potentially life-threatening hospital-borne infections, has developed several mechanisms to beat the potentially lethal effects of chemotherapeutic agents. Of these bacterial tricks, the most important was the acquisition of a foreign gene - the mecA gene - that confers resistance to methicillin in addition to penicillin and a host of other antibiotics, all belonging to what scientists refer to as the beta-lactam class of antibiotics.

Today, almost half of all staphylococcal infections in U.S. hospitals are caused by these methicillin-resistant S. aureus (MRSA) strains. By studying the bacteria's resistance mechanisms at the molecular level, researchers in the Laboratory of Microbiology at Rockefeller, working with researchers in the Laboratory of Molecular Genetics at the Instituto de Tecnologia Qumica e Biolgica, Universidade Nova de Lisboa, Portugal, hope to come up with new strategies for fighting such resilient microbes.

The beta-lactam class of antibiotics kills bacteria by binding to and inacti
'"/>

Contact: Whitney Clavin
clavinw@rockefeller.edu
212-327-7900
Rockefeller University
21-Aug-2001


Page: 1 2 3

Related biology news :

1. Molecular motor implicated in tissue remodeling
2. New fruitfly model of diabetes has future implications for pancreatic cell transplantation
3. Computer models expose humans as main cause of caribou decline
4. New model can aid in understanding immune system diseases
5. Physics gravity model applicable to disease spread
6. BioMed Central to consult funders and librarians over Open Access payment model
7. Study reveals surprising remodeling property of gene regulation process
8. Gene therapy reaches muscles throughout the body and reverses muscular dystrophy in animal model
9. Genetic model for devastating form of paraplegia suggests new treatments
10. New model explains why costly insect outbreaks hard to predict
11. A genetic model for hereditary spastic paraplegia (HSP) disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/25/2018)... ... 2018 , ... Researchers at the Icahn School of Medicine ... a long-standing computational concept known as “blacklisting,” which is commonly employed as a ... as a filter to single out genetic variations in patient genomes and exomes ...
(Date:12/19/2018)... ... December 19, 2018 , ... OrthoSpace Ltd. ... Arthroscopy evaluating the use of novel surgical techniques, including the OrthoSpace ... represent a painful, disabling condition for which there are historically few treatment options. ...
(Date:12/13/2018)... ... ... Study Protocol Summary of QC Procedure , 1 – Patient Enrolment (with ... the site., 3 - Three photos captured with Apple iPad and transferred to each ... Photos moved to eAdjudication® and submitted to Reviewers., 6 - Reviewers (blinded) repeats ...
Breaking Biology News(10 mins):
(Date:1/10/2019)... ... ... adopted from a local shelter when he was around two years old. According to ... after he was adopted, he tore his right cruciate ligament. Though he had his ... a traumatic injury. , Sure enough, when Rascal was about nine years old, he began ...
(Date:1/8/2019)... ... 08, 2019 , ... The American Society of Gene and Cell Therapy’s ... selection committee made up of industry leaders identified by the ASGCT board of directors. ... awards created to support ASGCT members designing transformative pilot studies in gene and cell ...
(Date:1/4/2019)... ... January 02, 2019 , ... CellMax Life ... cells in blood, has been named as a partner in Medigen Biotech’s upcoming ... cell therapies for cancer treatment, will use CellMax Life’s circulating tumor cell platform ...
(Date:12/19/2018)... FREDERICK, Md. (PRWEB) , ... December 19, 2018 ... ... solutions for Life Science, announces the validated release of Limfinity® version 7.1. The ... another important technical offering from RURO as 2018 comes to an end. , ...
Breaking Biology Technology:
Cached News: